LINEAGE CELL THERAPEUTICS - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Serial Number
97794652
Word Mark
LINEAGE CELL THERAPEUTICS
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2023-02-17
Filing Date
2023-02-14
Attorney Name
Statements
Indication of Colors claimed
The color(s) dark blue, light blue, orange, and gray is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a dark blue horizontal line followed by three light blue horizontal lines followed by five light blue and orange horizontal lines, immediately followed by the stylized word "LINEAGE" in gray stacked on top of the stylized words "CELL THERAPEUTICS" in gray.
Goods and Services
Pharmaceutical preparations and compositions for therapeutic use and treatment in the areas of ophthalmology, neurological conditions, oncology, neurotology; pharmaceutical preparations and compositions for cell therapy treatment and transplant medicine
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2023-02-17
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
HAROLD MILSTEIN
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2023-02-17 | NEW APPLICATION ENTERED |
